IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 265 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.49 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $73,159 | -56.2% | 16,079 | -7.7% | 0.02% | -66.2% |
| Q3 2022 | $167,000 | -42.2% | 17,419 | +0.2% | 0.06% | -59.6% |
| Q1 2022 | $289,000 | +21.4% | 17,380 | +39.5% | 0.16% | +15.0% |
| Q4 2021 | $238,000 | -19.9% | 12,462 | +3.5% | 0.14% | -25.1% |
| Q3 2021 | $297,000 | +40.8% | 12,035 | +56.9% | 0.19% | -33.0% |
| Q2 2020 | $211,000 | -35.9% | 7,670 | -35.4% | 0.28% | +5.3% |
| Q4 2019 | $329,000 | +41.8% | 11,878 | -13.4% | 0.26% | +373.2% |
| Q1 2018 | $232,000 | – | 13,713 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 2,222,701 | $25,005,000 | 8.92% |
| Broadfin Capital, LLC | 4,894,361 | $55,062,000 | 8.10% |
| GREAT POINT PARTNERS LLC | 3,496,340 | $39,334,000 | 6.13% |
| FRAZIER MANAGEMENT LLC | 2,188,331 | $24,619,000 | 4.51% |
| Prosight Management, LP | 715,317 | $8,047,000 | 4.49% |
| Avoro Capital Advisors LLC | 8,662,720 | $97,456,000 | 4.48% |
| QVT Financial LP | 821,361 | $8,748,000 | 2.26% |
| Perceptive Advisors | 7,290,199 | $82,014,000 | 2.19% |
| Rhenman & Partners Asset Management AB | 1,290,495 | $14,518,000 | 1.46% |
| EMORY UNIVERSITY | 185,915 | $2,092,000 | 1.37% |